Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Groundbreaking Two-Part transplant aims to fix diabetes and immune system in kids

NCT ID NCT03835312

Summary

This study is testing a new two-step treatment for children with a rare, severe genetic condition that causes both type 1 diabetes and a weakened immune system. First, doctors transplant umbilical cord blood stem cells to try to rebuild the child's immune system. If that is successful, they then transplant insulin-producing islet cells to potentially restore the body's ability to manage blood sugar. The goal is to control both the diabetes and the immune problems, which can be life-threatening.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Children's Hospital of Fudan University

    RECRUITING

    Shanghai, Shanghai Municipality, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.